Ligand validation:2E9L

PLM: PALMITIC ACID

PLM is a Ligand Of Interest in 2E9L designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2E9L_PLM_A_1001	5%	58%	0.275	0.675	0.67	0.94	-	2	1	0	100%	0.5
2E9L_PLM_A_1101	1%	64%	0.335	0.529	0.53	0.83	-	-	0	0	100%	1
2E9M_PLM_A_1001	32%	61%	0.174	0.848	0.51	0.96	-	1	2	0	100%	1
3VKK_PLM_A_474	5%	60%	0.198	0.61	0.47	1.04	-	2	4	0	100%	0.25
2ZOX_PLM_A_475	5%	62%	0.305	0.705	0.52	0.92	-	-	2	0	100%	1
4BVM_PLM_A_1132	98%	53%	0.062	0.988	0.62	1.17	-	2	1	0	100%	0.46
6S2S_PLM_A_203	98%	44%	0.069	0.988	1.32	0.86	4	-	1	0	100%	0.5
3CUE_PLM_E_194	98%	36%	0.075	0.994	1.12	1.37	1	3	6	0	100%	0.9444
4N03_PLM_A_601	95%	53%	0.07	0.974	0.81	1.02	-	1	0	0	100%	0.9167
5B27_PLM_A_201	94%	61%	0.086	0.985	0.63	0.85	-	1	0	0	100%	0.53

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.